Oncogenic effects of urotensin-II in cells lacking tuberous sclerosis complex-2.
Goldberg AA, Joung KB, Mansuri A, Kang Y, Echavarria R, Nikolajev L, Sun Y, Yu JJ, Laporte SA, Schwertani A, Kristof AS.
Goldberg AA, et al. Among authors: echavarria r.
Oncotarget. 2016 Sep 20;7(38):61152-61165. doi: 10.18632/oncotarget.10748.
Oncotarget. 2016.
PMID: 27458154
Free PMC article.